smith barney citigroup 2005 healthcare conference jp garnier chief executive officer glaxosmithkline environment demand the elderly consume more medicines ages 0 18 19 64 65 4 average prescriptions per year rx 11 24 aged 60 growing from 45 million to 83 by 2025 source kaiser family foundation state health facts funding us medicare europe rest of world key questions will program find sponsors it impact open access its cost exceed budget global market product ranking asthma advair 1 oral anti diabetic avandia met hiv combivir heart failure coreg nasal steriods flonase migraine imitrex herpes valtrex emetics zofran gsk leading products ims data value mat september 2004 is department hhs december report emphasis added overall national savings legalized importation likely be a small percentage total drug spending and developing implementing such would incur significant costs require additional authorities reputation comparative industries technology retail 2 pharmaceutical 3 consumer airlines 5 telecom 6 automotive 7 energy utilities 8 insurance
